This inventor holds 3 USPTO granted patents and 14 published patent applications and 2 EPO patents. Top assignee: Cell Cure Neurosciences Ltd. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Lior Ann Rosenberg Belmaker: Innovator in RPE Cell Research
Introduction
Lior Ann Rosenberg Belmaker is a notable inventor based in Shoham, Israel. He has made significant contributions to the field of retinal pigment epithelium (RPE) cell research. With a total of two patents to his name, his work focuses on innovative methods for generating RPE cell populations.
Latest Patents
Belmaker's latest patents include groundbreaking research on RPE cell populations and methods of generating the same. His patents disclose a population of human polygonal RPE cells, where at least 95% of the cells co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP). Notably, the trans-epithelial electrical resistance of these cells exceeds 100 ohms. These methods of generating RPE cells are crucial for advancements in retinal therapies.
Career Highlights
Lior Ann Rosenberg Belmaker is currently associated with Cell Cure Neurosciences Ltd. His work at this company emphasizes the importance of RPE cells in treating retinal diseases. His innovative approaches have positioned him as a key figure in the field of neuroscience and regenerative medicine.
Collaborations
Belmaker collaborates with esteemed colleagues such as Osnat Bohana-Kashtan and Ofer Wiser. Their combined expertise enhances the research and development of RPE cell technologies.
Conclusion
Lior Ann Rosenberg Belmaker's contributions to RPE cell research are paving the way for future advancements in retinal therapies. His innovative patents and collaborations highlight his commitment to improving medical science.